All Journal articles – Page 3
-
JournalIVD5: Navigating conformity assessment for IVDs – Challenges and opportunities
This is a report of the HM5/MD1/IVD1 session that took place at this year’s Symposium.
-
JournalIVD6: The evolution of the In Vitro Diagnostic Regulation
This is a report of the IVD6 session that took place at this year’s Symposium.
-
JournalMD7: Updates on Artificial Intelligence legislation and policy
This is a report of the MD7 session that took place at this year’s Symposium.
-
JournalMD8: Post-market challenges for medical devices
This is a report of the MD8 session that took place at this year’s Symposium.
-
JournalMD5: The evolution of the EU Medical Device Regulation
This is a report of the MD5 session that took place at this year’s Symposium.
-
JournalMD6: The importance of digital health – Digital Health Applications (DiGA) and the Digital Mental Health Technology Project
This is a report of the MD6 session that took place at this year’s Symposium.
-
JournalMD4/IVD4: Bridging the gaps – Developments in medical device and IVD regulatory harmonisation
This is a report of the MD4/IVD4 session that took place at this year’s Symposium.
-
JournalMD2/IVD2: Clinical investigation with medical devices
This is a report of the MD2/IVD2 session that took place at this year’s Symposium.
-
JournalMD3/IVD3: A global snapshot – Non-EU regulatory updates for medical devices and IVDs
This is a report of the MD3/IVD3 session that took place at this year’s Symposium.
-
JournalSME1: Regulatory updates for SMEs, academia and start-ups
This is a report of the SME1 session that took place at this year’s Symposium.
-
JournalPS1: Tailored development of biosimilars without efficacy and safety studies – Is this the future?
This is a report of the PS1 session that took place at this year’s Symposium.
-
JournalHM10: Strengthening Europe’s clinical trials competitiveness
This is a report of the HM10 session that took place at this year’s Symposium.
-
JournalPS2: Navigating the green horizon – Environmental sustainability and regulatory affairs
This is a report of the PS2 session that took place at this year’s Symposium.
-
JournalHM7: First experiences with the HTA Regulation
This is a report of the HM7 session that took place at this year’s Symposium.
-
JournalHM8: ePI is on FHIR – Preparing for implementation
This is a report of the HM8 session that took place at this year’s Symposium.
-
JournalHM9: From barrier to bridge – Practical strategies for successful advanced therapy medicinal product (ATMP) development
This is a report of the HM9 session that took place at this year’s Symposium.
-
JournalHM4: Revision of the EU Variation Regulation – Continuing innovation in lifecycle management
This is a report of the HM3 session that took place at this year’s Symposium.
-
JournalHM1: General pharmaceutical legislation - Platform technology and sandbox approaches
This is a report of the HM1 session that took place at this year’s Symposium.
-
JournalHM2: Fireside chat
This is a report of the HM2 session that took place at this year’s Symposium.
-
JournalHM3: Applying Artificial Intelligence in real life
This is a report of the HM3 session that took place at this year’s Symposium.